PLEASE DONATE To the TOXIC MOLD VICTIMS Dental & Medical Fund
I
have had numerous people complain about the quality of these documents.
Video cards & monitor settings differ from PC to PC so of course quality issue arise when viewing such documents. Websites knock resolutions down so that items can be viewed from all computers & not just the ones with $600 video cards.
Print these out by double clicking them & printing & if you still have issues THEN ask me to print these & mail them off to you. Thank you....
Pathology Report
Date Collected: 10/27/2009
Date Received: 11/05/2009
Attending Physician: Dr. Pollan,
PMFS Strong Memorial Hospital
601 Elm. Ave. Box 705
Rochester, NY 14642
Specimen Identification: Right Buccal Mucosa, lesion present for unknown period of time.
Clinical History: Peter Helfrich has been exposed to toxic fungi within his apartment.
Specimen Description: The specimen, labeled tissue for slide prep documentation only, consists of two tan-red fragments aggregating to 0.9 x 0.8 x 0.3 cm, completely submitted in one cassette for slide prep documentation only.
Microscopy: One Specimen
• There is a moderate amount of basket-weave fibrinous inflammation observed on the mucosal surface in a uniform application.
• There is thickening of the epidermis of between 8-16 cells thick. Normal thickness of epidermis is 1-3 cells.
• The Buccal biopsy does extend to the full depth of the muscle layer to reveal the full depth of the fibrin deposition.
• There is hyaline-appearing fibrinous inflammation just beneath the basement membrane and it continues well into the deep tissue including muscle, demonstrating the classic fingerprint of moderate chronic exposure of a year in duration to Trichothecene Mycotoxins.
• Several arteries are partially occluded with fibrinous inflammation or exudates, which is typical of all arteries of the body, and consistent with severe poisoning of the Trichothecene Mycotoxins. There are 30 microns of fibrin deposited within these arteries.
• The fibrinous inflammation is also indicative of ongoing ambient inhalation exposure to the highly poisonous Trichothecene Mycotoxins. The uniform reaction observed to the dermis is consistent with fungal vapors of Trichothecene Mycotoxins.
• Fibrinous inflammation is formed in the body when it is exposed to Trichothecene Mycotoxins. The fingerprint is highly specific and no other chemical exposure will cause this.
• The small arteries indicate a severe yeast infection within the systemic circulation. There is a severe infection of yeast observed within the small arteries.
• The buccal tissue reveals a strong positive reaction to Trichothecene Mycotoxins by filling the deep dermis with fibrin. There also is moderate amount of muscle necrosis observed. This confirms the fact that when Mycotoxins are present within the tissue, fibrin is also found.
• The stage of progression of this chemical poisoning of Trichothecene Mycotoxins is evaluated as Late Stage II.
• On examination of the buccal tissue no neoplastic cells were observed.
Diagnosis
The pathology clearly demonstrates severe chronic poisoning for a year in duration to Late Stage II from exposure to the highly irritating epoxides, Trichothecene Mycotoxins, via vapors, dermal contact and inhalation, which is consistent with the formation and progression of the disease called Trichothecene Mycotoxicosis. There are severe yeast organisms observed within the small arteries of the buccal tissue.
_________________________________________
William A. Croft, DVM, PhD, Medical Pathologist
Significance of Tissue Biopsy
Peter Helfrich clearly demonstrates cellular poisoning to the extent of Late Stage II in progression of the disease called Trichothecene Mycotoxicosis within his body. The severity of the fibrinous inflammation in the arteries observed within the buccal tissue, similar to skin is indicative of the state of the rest of the arteries within the body. The integumentary (skin) is of substantial importance and can be used for diagnostic purposes. ,
These highly poisonous epoxide chemicals react systemically, in other words, with all the body’s organs and systems in a generalized diffuse fashion in a stealth manner. By examination of arteries in one organ, a clear picture is available of what will be present in other arteries and other organs with the same extent of damage.
The biology, pathology, and the fingerprint of Trichothecene Mycotoxicosis resulting from consumption, dermal exposure, and inhalation has been well-established in humans and animals and has been widely reported , , , , in the available medical and scientific literature.
There is significant evidence that points to moderate loss of tissue cells and fibrinous inflammation of the other major organs and systems: brain, lung, heart, liver, spleen, kidneys, pancreas and the gastrointestinal, cardiovascular, skeletal, reproductive, lymphatic and immune systems in humans after exposure to Trichothecene Mycotoxins. In most cases, the necrosis, or dead tissue cells from these organs will not be regenerated or replaced.
The reduction and eventual removal of the Trichothecene Mycotoxins that caused fibrinous inflammation indicating Mycotoxin exposure is of the utmost importance in the therapeutic approach of patients with this level of progression of the disease. In cases of continued exposure to the Trichothecene Mycotoxins the intestinal mucosa cannot regenerate and will slough leading to the starvation of the patients. Patients should be made aware of this health condition and attempt to remove themselves from contaminated environments. At this stage in the disease, without treatment of the affected systems, the prognosis is poor, and with therapy the prognosis is guarded to good. Major efforts must also be made to control yeast infection within the body, which is consistent with Trichothecene Mycotoxin exposure.
THERAPY: Treatment of fibrinous inflammation can only be accomplished under a strict set of controlled conditions:
• Controlled environment that is totally free of Mycotoxins.
• Rehabilitative therapy using nutritive means.
• Monitor patient for fungal infection and yeast infection due to the severe immune depression.
• The patient should also be watched and monitored for development of cancer within the following organs: brain, spinal column, respiratory system, liver, spleen, kidney, urinary bladder, lymph nodes, thyroid, parathyroid, hormonal glands, including pituitary gland, gastrointestinal system, reproductive system including breast, pancreatic, skeletal, muscle and skin.
• Peter Helfrich is 33 years of age. The LD-50 (lethal dose at 50%) of Trichothecene Mycotoxins is 500 parts per billion/kg. The patient’s exposure can be computed by dividing the patient’s weight (138 lbs) by 2.2 pounds, will yield 62.7 kg, and multiply that times 90 ppb/kg will yield 5.6 mg, Daryl Stasky exposure to the highly poisonous epoxide chemicals, Trichothecene Mycotoxins, at minimum levels.
• In laboratory rats 500 parts per billion/kg deposited 20-21 microns of fibrin within the small arteries. Peter Helfrich expressed 30 microns of fibrin deposition or equal to 500 ppb/kg or 44.76, Peter Helfrich’s exposure to Trichothecene Mycotoxins on a pathological level. That amount of Trichothecene Mycotoxins is highly significant biologically1-8 and puts Peter Helfrich in Late Stage II of this disease.
Conclusion
It is my opinion to a reasonable degree of pathologic, scientific and medical certainty that the ingestion, dermal exposure and inhalation of Trichothecene Mycotoxins by Peter Helfrich has caused a high number of adverse health effects to the central nervous system, brain, spinal cord, peripheral nervous system, skeletal, respiratory, cardiovascular, digestive, hepatic, pancreatic, renal, reproductive, lymphatic and immune systems and remaining systems.
It is my opinion to a reasonable degree of scientific and pathologic certainty that the available scientific and medical peer-reviewed publications, research literature and studies relating to the adverse and toxic health effects caused by inhalation, dermal exposure and ingestion of Mycotoxins are reliable and widely accepted in their relevant scientific and medical communities.
The opinions I have expressed in this case conform to the current body of peer-reviewed scientific and medical literature, which is generally accepted as reliable in both the scientific and medical communities.
______________________________________________
William A. Croft, DVM, PhD, Medical Pathologist
WAC/kmg
I
have had numerous people complain about the quality of these documents.
Video cards & monitor settings differ from PC to PC so of course quality issue arise when viewing such documents. Websites knock resolutions down so that items can be viewed from all computers & not just the ones with $600 video cards.
Print these out by double clicking them & printing & if you still have issues THEN ask me to print these & mail them off to you. Thank you....
Pathology Report
Issued: 11/07/09 ID# MR00035017
Subject Name: HELFRICH, PETER
Specimen #: S-09-18590
Sex: M
Date Collected: 10/27/2009
Date Received: 11/05/2009
Attending Physician: Dr. Pollan,
PMFS Strong Memorial Hospital
601 Elm. Ave. Box 705
Rochester, NY 14642
Specimen Identification: Right Buccal Mucosa, lesion present for unknown period of time.
Clinical History: Peter Helfrich has been exposed to toxic fungi within his apartment.
Specimen Description: The specimen, labeled tissue for slide prep documentation only, consists of two tan-red fragments aggregating to 0.9 x 0.8 x 0.3 cm, completely submitted in one cassette for slide prep documentation only.
Microscopy: One Specimen
• There is a moderate amount of basket-weave fibrinous inflammation observed on the mucosal surface in a uniform application.
• There is thickening of the epidermis of between 8-16 cells thick. Normal thickness of epidermis is 1-3 cells.
• The Buccal biopsy does extend to the full depth of the muscle layer to reveal the full depth of the fibrin deposition.
• There is hyaline-appearing fibrinous inflammation just beneath the basement membrane and it continues well into the deep tissue including muscle, demonstrating the classic fingerprint of moderate chronic exposure of a year in duration to Trichothecene Mycotoxins.
• Several arteries are partially occluded with fibrinous inflammation or exudates, which is typical of all arteries of the body, and consistent with severe poisoning of the Trichothecene Mycotoxins. There are 30 microns of fibrin deposited within these arteries.
• The fibrinous inflammation is also indicative of ongoing ambient inhalation exposure to the highly poisonous Trichothecene Mycotoxins. The uniform reaction observed to the dermis is consistent with fungal vapors of Trichothecene Mycotoxins.
• Fibrinous inflammation is formed in the body when it is exposed to Trichothecene Mycotoxins. The fingerprint is highly specific and no other chemical exposure will cause this.
• The small arteries indicate a severe yeast infection within the systemic circulation. There is a severe infection of yeast observed within the small arteries.
• The buccal tissue reveals a strong positive reaction to Trichothecene Mycotoxins by filling the deep dermis with fibrin. There also is moderate amount of muscle necrosis observed. This confirms the fact that when Mycotoxins are present within the tissue, fibrin is also found.
• The stage of progression of this chemical poisoning of Trichothecene Mycotoxins is evaluated as Late Stage II.
• On examination of the buccal tissue no neoplastic cells were observed.
Diagnosis
The pathology clearly demonstrates severe chronic poisoning for a year in duration to Late Stage II from exposure to the highly irritating epoxides, Trichothecene Mycotoxins, via vapors, dermal contact and inhalation, which is consistent with the formation and progression of the disease called Trichothecene Mycotoxicosis. There are severe yeast organisms observed within the small arteries of the buccal tissue.
_________________________________________
William A. Croft, DVM, PhD, Medical Pathologist
Significance of Tissue Biopsy
Peter Helfrich clearly demonstrates cellular poisoning to the extent of Late Stage II in progression of the disease called Trichothecene Mycotoxicosis within his body. The severity of the fibrinous inflammation in the arteries observed within the buccal tissue, similar to skin is indicative of the state of the rest of the arteries within the body. The integumentary (skin) is of substantial importance and can be used for diagnostic purposes. ,
These highly poisonous epoxide chemicals react systemically, in other words, with all the body’s organs and systems in a generalized diffuse fashion in a stealth manner. By examination of arteries in one organ, a clear picture is available of what will be present in other arteries and other organs with the same extent of damage.
The biology, pathology, and the fingerprint of Trichothecene Mycotoxicosis resulting from consumption, dermal exposure, and inhalation has been well-established in humans and animals and has been widely reported , , , , in the available medical and scientific literature.
There is significant evidence that points to moderate loss of tissue cells and fibrinous inflammation of the other major organs and systems: brain, lung, heart, liver, spleen, kidneys, pancreas and the gastrointestinal, cardiovascular, skeletal, reproductive, lymphatic and immune systems in humans after exposure to Trichothecene Mycotoxins. In most cases, the necrosis, or dead tissue cells from these organs will not be regenerated or replaced.
The reduction and eventual removal of the Trichothecene Mycotoxins that caused fibrinous inflammation indicating Mycotoxin exposure is of the utmost importance in the therapeutic approach of patients with this level of progression of the disease. In cases of continued exposure to the Trichothecene Mycotoxins the intestinal mucosa cannot regenerate and will slough leading to the starvation of the patients. Patients should be made aware of this health condition and attempt to remove themselves from contaminated environments. At this stage in the disease, without treatment of the affected systems, the prognosis is poor, and with therapy the prognosis is guarded to good. Major efforts must also be made to control yeast infection within the body, which is consistent with Trichothecene Mycotoxin exposure.
THERAPY: Treatment of fibrinous inflammation can only be accomplished under a strict set of controlled conditions:
• Controlled environment that is totally free of Mycotoxins.
• Rehabilitative therapy using nutritive means.
• Monitor patient for fungal infection and yeast infection due to the severe immune depression.
• The patient should also be watched and monitored for development of cancer within the following organs: brain, spinal column, respiratory system, liver, spleen, kidney, urinary bladder, lymph nodes, thyroid, parathyroid, hormonal glands, including pituitary gland, gastrointestinal system, reproductive system including breast, pancreatic, skeletal, muscle and skin.
• Peter Helfrich is 33 years of age. The LD-50 (lethal dose at 50%) of Trichothecene Mycotoxins is 500 parts per billion/kg. The patient’s exposure can be computed by dividing the patient’s weight (138 lbs) by 2.2 pounds, will yield 62.7 kg, and multiply that times 90 ppb/kg will yield 5.6 mg, Daryl Stasky exposure to the highly poisonous epoxide chemicals, Trichothecene Mycotoxins, at minimum levels.
• In laboratory rats 500 parts per billion/kg deposited 20-21 microns of fibrin within the small arteries. Peter Helfrich expressed 30 microns of fibrin deposition or equal to 500 ppb/kg or 44.76, Peter Helfrich’s exposure to Trichothecene Mycotoxins on a pathological level. That amount of Trichothecene Mycotoxins is highly significant biologically1-8 and puts Peter Helfrich in Late Stage II of this disease.
Conclusion
It is my opinion to a reasonable degree of pathologic, scientific and medical certainty that the ingestion, dermal exposure and inhalation of Trichothecene Mycotoxins by Peter Helfrich has caused a high number of adverse health effects to the central nervous system, brain, spinal cord, peripheral nervous system, skeletal, respiratory, cardiovascular, digestive, hepatic, pancreatic, renal, reproductive, lymphatic and immune systems and remaining systems.
It is my opinion to a reasonable degree of scientific and pathologic certainty that the available scientific and medical peer-reviewed publications, research literature and studies relating to the adverse and toxic health effects caused by inhalation, dermal exposure and ingestion of Mycotoxins are reliable and widely accepted in their relevant scientific and medical communities.
The opinions I have expressed in this case conform to the current body of peer-reviewed scientific and medical literature, which is generally accepted as reliable in both the scientific and medical communities.
______________________________________________
William A. Croft, DVM, PhD, Medical Pathologist
WAC/kmg